glp-1 connecticut Weight Loss in GLP-1 Prescription in Connecticut (CT)

The rising appeal of GLP-1 drugs for cosmetic weight loss has led to a significant increase in off-label prescribing, which can result in unnecessary claims, legal or ethical dilemmas and the risk of poor health outcomes for individuals who may not receive the right support for their condition

Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach

According to a clinical trial of Ozempic, after 68 weeks on the medication, 86.4% of participants lost 5% or more of their body weight, and 69.1% lost 10% or more of their body weight. While weight loss can bring about health benefits, losing weight rapidly can also cause a decrease in muscle mass, lessen bone density, and lower your resting metabolic rate, leading to sarcopenia the gradual loss of muscle mass, strength, and function

Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans